Medication Therapy Management (MTM) Clinic

Slides:



Advertisements
Similar presentations
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Advertisements

Disease State Management The Pharmacist’s Role
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Drug Utilization Review (DUR)
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Medication Therapy Management Linda Mach, PharmD Bartell Drugs Community Practice Resident February 26, 2010.
Clinical Pharmacy II Lobna Al Juffali,MSc Fall-2009.
Chronic Disease Management – Role of the Community Pharmacist Andrew J. Burr.
Omnibus Budget Reconciliation Act (OBRA-90) Goal To save money.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Ambulatory Care Pharmacy
Establishing Preventive Cardiology Programs Nathan Wong Nathan Wong.
Meeting the health needs of older drug users Dr Muriel Simmonte NHS Lothian Primary Care Facilitator Team/East Lothian Locality Drug Clinic.
Wayne County Hub Discharge Planning Valerie Langley, RN, Nurse Manager Wayne County Hub NC Department of Corrections May 2, 2007.
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
Community Health Team Care Management Process PinnacleHealth Systems Don DeArmitt, M.D. Becky E. Zook RN, BSN, MS, CCP.
Managing Medications in Clinically Complex Elders Michael A. Steinman, MD, Joseph T. Hanlon, PharmD, MS JAMA, Oct 13, 2010, Vol 304, No 14 Payal Patel.
Medicare Annual Wellness Exam Presented by: Susan Duden, CPC. March 24, 2012.
CustomCare Programs After the Hospital and TLC Tracy Lin, PharmD, CACP After the Hospital At Home TLC.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
5 th Annual Lourdes Cardiology Services Symposium: Cardiology for Primary Care.
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
© 2013 sanofi-aventis U.S. LLC, A SANOFI COMPANY All rights reserved Printed in the USA US.NMH Do not copy. Do not distribute. Do not leave behind.
Bryan Bray, Pharm.D., CPP Chief Operating Officer Medication Management, LLC Vice President of Clinical Services Piedmont Pharmaceutical Care Network,
Component 1: Introduction to Health Care and Public Health in the U.S. Unit 3: Delivering Healthcare (Part 2) Organization Of Primary Care Clinics.
Clinical Pharmacy Part 2
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.
Mary Gardner, RN, MA, CCM, CDE Program Manager, High Risk Diabetes and COPD XLHealth Member Management Using The Med-eXpert System and Med-eMonitor Patient.
Nursing Process: The Foundation for Safe and Effective Care Chapter 5.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Transitions of Care: Using Pharmacists as Part of Team Based Care Care Transformation Collaborative of R.I. TARA HIGGINS, PHARMD, CDOE, CVDOE CLINICAL.
Introduction.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Multidisciplinary Diabetes Team Activities in a 196 Bed Community Hospital Robin Southwood, Pharm.D, CDE and Beth Melvin, RD, MS, CDE.
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
MTM Medication Therapy Management. What is Medication Therapy Management? From 1996 to 2006, the number of prescription medications dispensed increased.
Medication Therapy Management Part D Programs Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2014.
Polypharmacy in a Patient Centered Medical Home Carilion Clinic – VTC Family Medicine Roanoke, Virginia.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Documentation in Practice Dept. of Clinical Pharmacy.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Wellness Group Visits: Development and Implementation Randall T. Forsch MD MPH University of Michigan November 19, 2006.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Grant Macdonald.  Appropriate polypharmacy describes treatment where a patient has multiple morbidities, and/or a complex condition, that is being managed.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
Medication therapy management
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
Nurse Patient Care Leadership (Nurse Team Manager) Staff Support
Medication Therapy Management (MTM)
Documentation of pharmaceutical care
clinical standards for health care information
Clinical Webinar: Integrated Pharmacy
Integration of Care Management and Pharmaco-Informatics
Strategies for Improving HEDIS Performance:
Medication Reconciliation ROP Compliance
Jessica Lobban, PGY-3 CCLP Family Medicine Residency Program
Clinical Pharmacy II.
Introduction to Clinical Pharmacy
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Treating Alcohol Abuse
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Sandeep Wadhwa, MD, MBA, Vice President, Care Management Services
Pharmacy practice experience I
Pharmacy practice and the healthcare system Ola Ali Nassr
Pharmaceutical care planning 2 Ola Ali Nassr
Clair Huckerby Consultant Pharmacist
Pharmaceutical care plans Ola Ali Nassr
Presentation transcript:

Medication Therapy Management (MTM) Clinic Christopher R. Lopez, PharmD, CDE Clinical Pharmacy Specialist: Population Health Accountable Care Organization (ACO) Support Team Dartmouth-Hitchcock October 14, 2014

Why Initiate an MTM Clinic? “Pharmaceuticals are the most common medical intervention and their potential for both help and harm is enormous. Ensuring that the American People get the most benefit from advances in pharmacology is a critical component of improving the National Healthcare System.” The Institute of Medicine (IOM)

Facts and Figures 75% of healthcare dollars are spent on chronic conditions ($1.3 trillion annually). Total financial impact of medication non-adherence is estimated at $240 billion annually. Almost 50% of the population is on at least one chronic prescription medication; Over 10% of the population uses 5 or more chronic prescription medications.

Identify Appropriate Patients Run workbench reports specific to: Insurance Coverage Number of medications To catch the most complex patients Problem list To identify patients with specific chronic disease states Age

Once Patients Are Identified… Allow PCP to review patients to ensure that they are appropriate for referral. Exclude inappropriate patients: Acute condition that would make an additional patient encounter less than ideal. Acute mental health exacerbation Ongoing chemotherapy treatments Patient in assisted living or skilled nursing facility Patient with dementia

Also Provide Guidelines for Provider Referral Patients meeting one or more of the following conditions are more apt to benefit from a consult: 1) Patient on 10 or more chronic medications. 2) Patient not meeting disease state parameters (e.g. A1c not at goal, most recent BP not at goal, etc.). 3) Patient on more than 2 chronic narcotics. 4) Elderly patients deemed to be a fall risk. 5) Patient unable to afford medications, and prohibitive cost is negatively impacting care and compliance. 6) Patient at high risk for ADR/drug-drug interactions.

The Logistics Must have the following in place: Process for scheduling patient into pharmacist clinic. Pharmacist must have appropriate EMR access. Exam room/ office to see patient and/or family members. Place for patient to check in. MAKE SURE ENTIRE FACILITY IS MADE AWARE OF THE SERVICE. Procedure for documentation and making recommendations to appropriate provider.

Billing/ Reimbursement Bill 3rd party (e.g. Medicare Part D)? Charge patient out-of-pocket? Justify pharmacist salary using cost savings/cost avoidance models, as well as ability to assist with clinical quality metrics?

The MTM Appointment Chart is reviewed prior to appointment Medication regimen/ Drug interaction screening Recent labs/ lab value trends Vitals Most recent encounter notes Allergies/documented ADR’s The actual appointment 45 Minutes Patient/ medication-focused Patients are encouraged to bring in all medications to appointment. All meds are reviewed.

AT is a 72-y/o male… With a past medical history significant for hypertension, diabetes, hyperlipidemia, depression, GERD, fibromyalgia, and insomnia who was referred for a MTM consult due to the existence of more than ten chronic medications. Note: He is currently on 17 chronic medications.

Recommendations: Streamline Med Regimen Patient is currently on several medications for hypertension, yet none of them are at max daily dose. If losartan dose were to be increased to 100 mg daily, perhaps amlodipine could be discontinued, resulting in one less medication and subsequent copay for this patient. Pt is currently on two medications for lipids. Recommend increase atorvastatin dose and discontinue fenofibrate.

Recommendation: Re-evaluate Therapy Pt complains of fibromyalgia pain and subsequent insomnia secondary to this pain. Pt is currently on sertraline and mirtazapine for depression, which he says is well controlled. Perhaps both of these could be discontinued and replaced with venlafaxine, which is an SNRI. Pt also taking zolpidem for insomnia.

Recommendation: Therapeutic Substitution for Better Outcome Pt states that he only uses esomeprazole as needed. This med (Nexium) just achieved OTC status, so it is very likely that his insurance will stop covering it. Since he is taking it to relieve GERD symptoms, and not daily as a maintenance medication, it should most likely be replaced by an H2 blocker like ranitidine. PPI's typically don't work well to alleviate symptoms of existing heartburn. H2's work much better.

Recommendation: Disease-state Management Pt is currently testing his blood glucose fasting in the AM and 30 min after meals. Pt was instructed to test post-prandially 2 hours after meals instead of 30 min. Pt verbalized understanding.

Recommendation: Potential for Serious ADR Increased risk of seizures is listed in the manufacturer's package labeling as a possibility when tramadol and sertraline are co-administered. Serotonin syndrome is also a potential risk with this combination. Recommend replace tramadol with a different agent.

Medication Reconciliation Discrepancies None (miraculously)

MTM Consult Data Approximately per every 20 MTM consults… 5 Critical drug-drug interactions were identified 5 Necessary subspecialty referrals were facilitated 6 Recommendations to avoid potentially serious adverse drug reactions (ADR’s) were identified 8 Incidents of improper prescribing were identified 97 Medication reconciliation discrepancies were identified 2 Problem list discrepancies were identified 71 “other” uncategorized recommendations were made

Thank you! Christopher R. Lopez, PharmD, CDE Christopher.r.lopez@hitchcock.org